News & Updates

Show Multimedia Only

Nintedanib continues to show promise for progressive fibrosing ILDs

03 Sep 2020 by

Interim analyses of the INBUILD trial presented at ATS 2020 continue to reflect the benefit of the tyrosine kinase inhibitor nintedanib for individuals with progressive fibrosing interstitial lung diseases (ILDs).

Nintedanib continues to show promise for progressive fibrosing ILDs

03 Sep 2020

Flavoured cigarette ban helps reduce smoking in youths

03 Sep 2020

A ban on flavoured cigarettes is an effective measure to curb cigarette use among young people, a recent study has found.

Flavoured cigarette ban helps reduce smoking in youths

03 Sep 2020

News & Updates

Filter by Specialty:

Specialty:

Nintedanib continues to show promise for progressive fibrosing ILDs

Nintedanib continues to show promise for progressive fibrosing ILDs

Flavoured cigarette ban helps reduce smoking in youths

Flavoured cigarette ban helps reduce smoking in youths